Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francois21on Feb 05, 2015 8:59pm
179 Views
Post# 23402183

RE:cnbg HK IPO

RE:cnbg HK IPOI think this IPO was delayed by chinese authorities if I recall well, but I'm not 100% sure about it. However, the relation with PLI and CNBG will have no effect on the IPO in my opinion. But, is this IPO could have some effect on this relation? Would CNBG be a Partner with PLI to go international in the fractionation business? IF CIBG have successfully scale up the 7 proteins, would they like to expand this partnership outside China using PPPS? PLI have the technology, only $$$ are missing....
Bullboard Posts